Purple InnovationPRPL
PRPL logo
Fair Value
US$25
Share price18 Aug
US$5.5377.9% undervalued intrinsic discount
Loading
1Y-80.42%
7D-18.92%

Nationwide Rollout And New Retail Partnerships Will Expand Premium Reach

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
06 Apr 25
Updated
18 Aug 26
Views
101
Not Invested

Last Update 18 Aug 26

Fair value Increased 22%

PRPL: Reverse Split And Higher Future P/E Will Reset Risk Reward

Analysts have raised their price target for Purple Innovation from $20.50 to $25.00, citing updated assumptions for revenue growth, profit margins, and future P/E levels in their valuation work.

What’s in the News for Purple Innovation

  • Purple Innovation revised full year 2026 earnings guidance and now sets revenue guidance in a range of $420 million to $440 million. Source, Company earnings guidance.
  • The company received a Nasdaq panel decision on July 20, 2026 that grants continued listing, conditional on Purple Innovation achieving a closing bid price of at least $1.00 per share for a minimum of ten consecutive trading days by July 31, 2026. Source, Nasdaq listing correspondence.
  • To support bid price compliance, stockholders approved a reverse stock split, and the Board set the final ratio at 1 for 25. The reverse stock split took effect before trading opened on July 20, 2026, and Purple Innovation common stock began split adjusted trading on Nasdaq that day at $7.12 per share. Source, Company stock split announcement.
  • Before the reverse split, Purple Innovation called a Special Meeting of Stockholders for July 2, 2026 to vote on an amendment to its certificate of incorporation that would allow a reverse stock split in a range of 1 for 10 to 1 for 30, with the exact ratio to be chosen by the Board. Source, Special meeting materials.
  • The July 2, 2026 Special Meeting of Stockholders was scheduled for 10:00 Mountain Standard Time, with the agenda to consider the reverse stock split amendment and other matters. Source, Company meeting notice.

Valuation Changes for Purple Innovation

  • Fair Value was raised from $20.50 to $25.00 per share, an increase of around 22% in the analyst model.
  • The Discount Rate was adjusted slightly from 12.46% to 12.54%, reflecting only a small change in the risk assumption used in the valuation.
  • Revenue Growth was reduced from 5.62% to 3.00%, indicating more conservative expectations for future dollar revenue expansion at Purple Innovation.
  • The Net Profit Margin was held essentially steady, moving from 5.25% to 5.25%, suggesting that profitability assumptions are largely unchanged.
  • The Future P/E increased from 4.09x to 5.48x, meaning the valuation model now applies a higher earnings multiple to Purple Innovation.
4 viewsusers have viewed this narrative update

Key Takeaways

  • Strategic expansion with leading retailers and innovation in premium products positions Purple to accelerate market penetration and capitalize on growing wellness trends.
  • Enhanced operational efficiencies and data-driven channel optimization are projected to strengthen margins, profitability, and long-term market leadership.
  • Heavy reliance on successful product launches and retail partnerships, plus margin pressures from tariffs and channel shifts, threatens profitability and future revenue growth.

Catalysts

About Purple Innovation
    Designs, manufactures, and sells sleep and other products in the United States and internationally.
What are the underlying business or industry changes driving this perspective?
  • Purple's expanding reach through the nationwide rollout with Mattress Firm, deepening partnerships with Costco and Walmart, and new large retailer distribution is set to rapidly increase its addressable market and premium product penetration, supporting potential revenue acceleration over the next several quarters.
  • The outperformance and strong early demand for the high-margin Rejuvenate 2.0 line, incorporating proprietary GelFlex and DreamLayer technology, signals increasing consumer willingness to spend on differentiated, health
  • and wellness-focused sleep products, suggesting enhanced long-term revenue growth and gross margin expansion.
  • Ongoing optimization and innovation within the DTC and showroom channels, coupled with a more data-driven and efficient marketing strategy, are expected to drive higher conversion rates and increasing average selling prices, directly improving net margins and profitability as the consumer sales mix shifts upmarket.
  • Operational efficiencies in sourcing, manufacturing (especially at the Georgia facility), and cost-saving initiatives-including successful tariff mitigation and a shift in supply chain strategy-are expected to restore and expand gross margins above 40% by year-end, supporting better EBITDA and long-term earnings.
  • Rising consumer focus on wellness, aging population needs, and channel shift to e-commerce (where Purple's technology and branding are distinct) position the company to benefit from enduring industry tailwinds, further boosting long-term revenue, market share, and net margin potential.
Purple Innovation Earnings and Revenue Growth

Purple Innovation Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Purple Innovation's revenue will grow by 3.0% annually over the next 3 years.
  • Analysts are not forecasting that Purple Innovation will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate Purple Innovation's profit margin will increase from -10.7% to the average US Consumer Durables industry of 5.3% in 3 years.
  • If Purple Innovation's profit margin were to converge on the industry average, you could expect earnings to reach $26.0 million (and earnings per share of $5.88) by about August 2029, up from -$48.7 million today.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 6.1x on those 2029 earnings, up from -0.6x today. This future PE is lower than the current PE for the US Consumer Durables industry at 14.3x.
  • Analysts expect the number of shares outstanding to grow by 0.54% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 12.54%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Heavy short-term reliance on new product launches (e.g., Rejuvenate 2.0) and major retail partnerships (like Mattress Firm) creates execution risk; delays, supply chain missteps, or demand overestimation could cause revenue volatility and inventory imbalances, negatively impacting top-line growth and earnings.
  • Tariff headwinds and the ongoing need for price increases or sourcing shifts introduce sustained cost and gross margin uncertainty; should tariffs worsen or mitigation efforts fall short, net margins could remain pressured, undermining profitability improvements and adjusted EBITDA targets.
  • Digital channel softness continues, with e-commerce sales declining and industry-wide trends showing over 80% of premium mattress customers still prefer in-person experience; failure to optimize or rejuvenate online DTC growth as shopping habits evolve may limit future revenue streams.
  • Increased marketing efficiency is still reliant on higher spending and evolving strategies, but as mattress category competition intensifies and brand differentiation risks rise (with similar grid/gel technologies proliferating), Purple may face diminishing returns on ad spend, further squeezing both gross profit and free cash flow.
  • Long-term industry trends of slow mattress replacement cycles and commoditization (due to new digital-first entrants and price competition from global players) risk eroding pricing power and margin expansion, potentially stalling sustainable revenue growth and leading to prolonged net losses.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $25.0 for Purple Innovation based on their expectations of its future earnings growth, profit margins and other risk factors.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $495.5 million, earnings will come to $26.0 million, and it would be trading on a PE ratio of 6.1x, assuming you use a discount rate of 12.5%.
  • Given the current share price of $6.31, the analyst price target of $25.0 is 74.8% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Purple Innovation?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Comments

0 comments

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value vs Share Price

US$25
vs US$5.5377.9% undervalued intrinsic discount
PastFuture-186m714m2015201820212024202620272029Revenue US$548.1mEarnings US$28.8m
6.5%
Revenue growth
5.3%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Purple Innovation

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Slight risk and fair value.

Market capUS$24.1m
PB-0.4x
Estimated Growth3.7%
Dividend YieldN/A
Full analysis

CEO & management

Robert DeMartini
CEO
4.3yrs
CEO Tenure

Designs, manufactures, and sells sleep and other products in the United States and internationally.